Abilify 2, 5, 10,
Depression, Bipolar
Korea Otsuka Pharmaceutical Co., Ltd.Phase 3Active
B
60/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 45/ 100
- Competitive Position
- 95/ 100
Competitive context
4 Active assets in the Depression, Bipolar cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Olanzapine China Medical University, China | Phase 4 | BBB |
ZIPRASIDONE Queen's University | Phase 4 | BBB |
Cariprazine Aalborg University Hospital | Phase 4 | BB |
Valproic Acid Ewha Womans University Mokdong Hospital | Phase 4 | BB |
Starch China Medical University, China | Phase 4 | BB |
View all 23 →
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →